JESSICA SHIFFNER: Open Payments
NPI 1295496438 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $341 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| PFIZER INC. | 5 | $96 |
| Lilly USA, LLC | 5 | $91 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Amgen Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Corcept Therapeutics | 1 | $21 |
Products named: AIRSUPRA, Ozempic, Wegovy, MOUNJARO, Rybelsus, NEXLETOL, ELIQUIS, PREVNAR 20.
Industry payments across FL — which companies pay providers there.
